08/14/2025
5:58 AM | Cullinan Therapeutics (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SCHEDULE 13G | |
08/08/2025
4:30 PM | Cullinan Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2025
4:30 PM | Allen Andrew R (Reporting)
Cullinan Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2025
4:30 PM | Allen Andrew R (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2025
4:30 PM | Cullinan Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2025
6:04 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
6:07 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2025
5:55 PM | CITADEL ADVISORS LLC (Filed by)
Cullinan Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/04/2025
3:04 PM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:21 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:24 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for CGEM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/25/2025
5:56 AM | Cullinan Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
5:58 AM | Cullinan Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:00 AM | Cullinan Therapeutics (Filer)
| Form ARS | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:03 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:07 AM | Cullinan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:11 AM | Cullinan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
6:00 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:22 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
5:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:06 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:18 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:18 AM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
10/31/2024
11:48 AM | Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G | |
10/16/2024
6:17 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:13 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:27 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access